Coprescription of Tamoxifen and Medications That Inhibit CYP2D6

Concomitant CYP2D6 inhibitor use and tamoxifen adherence in early-stage breast cancer: A pharmacoepidemiologic study

(2017) V. Dezentje et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk of breast cancer recurrence in women initiating tamoxifen with CYP2D6 inhibitors

(2017) R. E. Aubert et al.   JOURNAL OF CLINICAL ONCOLOGY

The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users

(2009) Monique J. Bijl et al.   BREAST CANCER RESEARCH AND TREATMENT

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2,*3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

(2009) Masatsugu Okishiro et al.   CANCER

The Tamoxifen Metabolite, Endoxifen, Is a Potent Antiestrogen that Targets Estrogen Receptor   for Degradation in Breast Cancer Cells

(2009) X. Wu et al.   CANCER RESEARCH

Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

(2009) Werner Schroth   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

(2009) Michael Gnant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment

(2008) Y. Xu et al.   ANNALS OF ONCOLOGY

Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy

(2008) Kazuma Kiyotani et al.   CANCER SCIENCE

Impaired Tamoxifen Metabolism Reduces Survival in Familial Breast Cancer Patients

(2008) W. G. Newman et al.   CLINICAL CANCER RESEARCH

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update

(2008) Edoardo Spina et al.   CLINICAL THERAPEUTICS

Effect of Desvenlafaxine on the Cytochrome P450 2D6 Enzyme System

(2008) Sheldon H. Preskorn et al.   Journal of Psychiatric Practice

Going from evidence to recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal